Actively Recruiting
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
Led by University of Southern California · Updated on 2025-12-04
20
Participants Needed
2
Research Sites
208 weeks
Total Duration
On this page
Sponsors
U
University of Southern California
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This clinical trial evaluates a golf recreational exercise program for enhancing survivorship in underrepresented prostate cancer survivors. Golf is a multimodal recreational activity that requires participants to utilize all muscle groups to perform the golf swing, walk over hilly and uneven terrain, maintain balance during putting and squat-like tasks. Physical activity and exercise are beneficial to physical function, cognitive function, psychosocial health, and overall quality of life during prostate cancer survivorship. These aspects of health are impacted by prostate cancer treatment, especially androgen deprivation therapy. Additionally, supervised, group-based activity programs facilitate participation in physical activity. Researchers want to examine the changes in functional abilities, psychosocial health, and quality of life following participation in in a golf program designed for prostate cancer survivors.
CONDITIONS
Official Title
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- First time, primary diagnosis of prostate cancer (PCa)
- Currently receiving androgen deprivation therapy (ADT) and/or androgen receptor blocker for more than 6 months
- Male aged 55 to 85 years
- Ability to stand independently without external support
- No or minimal golf experience (played less than 5 times in the past 10 years)
- English speaking
You will not qualify if you...
- Second cancer diagnosis (excluding non-invasive skin cancers) or bone metastases
- Prostatectomy less than 6 months prior to study enrollment
- Symptomatic cardiovascular disease, active angina, uncontrolled hypertension (SBP > 160 or DBP > 90), high resting heart rate (> 90), symptomatic orthostatic hypotension
- Unstable asthma or exacerbated chronic obstructive pulmonary disease (COPD)
- Injury or orthopedic operation within the last 6 months
- Movement disorders such as Parkinson's disease or other neurological disorders, hemiparesis or paraparesis
- Severe vision or hearing problems
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Los Angeles General Medical Center
Los Angeles, California, United States, 90033
Actively Recruiting
2
USC / Norris Comprehensive Cancer Center
Los Angeles, California, United States, 90033
Actively Recruiting
Research Team
G
Garry Cai
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here